SETDB2 and RIOX2 are differentially expressed among renal cell tumor subtypes, associating with prognosis and metastization

Increasing detection of small renal masses by imaging techniques entails the need for accurate discrimination between benign and malignant renal cell tumors (RCTs) as well as among malignant RCTs, owing to differential risk of progression through metastization. Although histone methylation has been...

ver descrição completa

Detalhes bibliográficos
Autor principal: Ferreira, Maria João (author)
Outros Autores: Pires-Luís, Ana Sílvia (author), Vieira-Coimbra, Márcia (author), Costa-Pinheiro, Pedro (author), Antunes, Luís (author), Dias, Paula C. (author), Lobo, Francisco (author), Oliveira, Jorge (author), Gonçalves, Celine Saraiva (author), Costa, Bruno Marques (author), Henrique, Rui (author), Jerónimo, Carmen (author)
Formato: article
Idioma:eng
Publicado em: 2017
Assuntos:
Biomarkers, Tumor
Carcinoma, Renal Cell
Chromosomal Proteins, Non-Histone
Disease-Free Survival
Female
Histone Demethylases
Histone-Lysine N-Methyltransferase
Humans
Kidney Neoplasms
Male
Neoplasm Metastasis
Nuclear Proteins
RNA
biomarker
histone methyltransferase
kidney cancer
metastasis
prognosis
renal cell tumor
renal cell carcinoma
RIOX2
SETDB2
Ciências Médicas::Medicina Básica
Science & Technology
Texto completo:http://hdl.handle.net/1822/57967
País:Portugal
Oai:oai:repositorium.sdum.uminho.pt:1822/57967

Texto Completo

http://hdl.handle.net/1822/57967

Registros relacionados